XML 31 R19.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Restructuring | 9 Months Ended
--- | ---
Oct. 01, 2017
Restructuring and Related Activities [Abstract] |
Restructuring | RESTRUCTURING The Company announced restructuring actions in its Medical Devices segment to better serve the needs of patients and customers in today’s evolving healthcare marketplace. The Company is undertaking actions to strengthen its go-to-market model, accelerate the pace of innovation, further prioritize key platforms and geographies, and streamline operations while maintaining high quality standards. The Company estimates that, in connection with its plans, it will record pre-tax restructuring and other charges of approximately $2.0 billion to $2.4 billion. In the fiscal nine months of 2017, the Company recorded a pre-tax charge of $476 million, of which $46 million was included in cost of products sold and $265 million was included in other (income) expense. In the fiscal third quarter of 2017, the Company recorded a pre-tax charge of $187 million, of which $29 million was included in cost of products sold and $89 million was included in other (income) expense. In the fiscal second quarter of 2017, the Company recorded a $90 million accrual adjustment to the severance reserve due to higher voluntary separation than anticipated. See the following table for additional details. Total project costs of $1.8 billion have been recorded since the restructuring announcement. Additionally, as part of the plan, the Company expects that the restructuring actions will result in position eliminations of approximately 4 to 6 percent of the Medical Devices segment’s global workforce over the next 15 months. Approximately 2,200 positions have been eliminated of which 1,700 received separation payments since the restructuring announcement. The Company estimates that approximately one half of the cumulative pre-tax costs will result in cash outlays, including approximately $400 million of employee severance. Approximately one half of the cumulative pre-tax costs are non-cash, relating primarily to facility rationalization, inventory write-offs and intangible asset write-offs. The following table summarizes the severance related reserves and the associated spending under this initiative through the fiscal nine months of 2017:
(Dollars in Millions) | Severance | Asset Write-offs | Other** | Total
Reserve balance, January 1, 2017 | $ | 380 |  | — |  | 1 |  | 381 |
Current year activity: |  |  |  |
Charges | — |  | 140 |  | 426 |  | 566 |
Cash payments | (45 | ) | — |  | (423 | ) | (468 | )
Settled non cash | — |  | (140 | ) | — |  | (140 | )
Accrual adjustment | (90 | ) | — |  | — |  | (90 | )
Reserve balance, October 1, 2017* | $ | 245 |  | — |  | 4 |  | 249 |
*Cash outlays for severance are expected to be substantially paid out over the next 2 years in accordance with the Company's plans and local laws. **Other includes project expense such as salaries for employees supporting the initiative and consulting expenses.

X
- References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -URI http://asc.fasb.org/topic&trid=2175745 + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration